A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05864924 |
Recruitment Status :
Completed
First Posted : May 18, 2023
Last Update Posted : May 8, 2024
|
Sponsor:
BioSyngen Pte Ltd
Information provided by (Responsible Party):
BioSyngen Pte Ltd
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | April 26, 2024 |
Actual Study Completion Date : | April 26, 2024 |